Stephan Krause, PhD, Bristol Myers Squibb

Krause, PhD, Executive Director for Cell Therapies at Bristol Myers Squibb and Chair of PDA’s ATMP Advisory Board, is a results-driven leader with technical, managerial, and executive experience. He has a proven background in leading quality and technical functions within global operations. Krause is a recognized leader of industry working groups to improve and standardize best practices for analytical and quality-focused processes. His breadth of experience includes mAbs, ADCs, ATMPs, vaccines, coagulation factors, small molecules and biosimilars